Search

REPRODUCTIVE FACTORS, OBESITY, AND RISK OF THYROID CANCER AMONG WOMEN: A MULTICENTER RESEARCH NETWORK ANALYSIS

Endocrine Surgery

Madison N Hearn, BS; Neerav Goyal, MD, MPH; Tonya King, PhD; David Goldenberg, MD, FACS

Penn State College of Medicine

ANAPLASTIC THYROID CANCER MANAGEMENT AND OUTCOMES: 20-YEAR SINGLE INSTITUTION EXPERIENCE

Endocrine Surgery

Shannon S Wu¹; Eric Lamarre, MD²; Anirudh Yalamanchali, MD, MS²; Philip Brauer³; Chandana A Reddy²; Emrullah Yilmaz, MD²; Neil Woody, MD²; Jamie Ku, MD²; Brandon Prendes, MD²; Christian Nasr, MD²; Mario Skugor, MD²; Katherine Heiden, MD²; Deborah Chute, MD²; Jeffrey Knauf, PhD⁴; Shauna R Campbell, DO²; Shlomo Koyfman, MD²; Jessica Geiger, MD²; Joseph Scharpf, MD²

¹Cleveland Clinic Lerner College of Medicine; ²Head and Neck Institute, Cleveland Clinic; ³Case Western Reserve University School of Medicine; ⁴Lerner Research Institute, Cleveland Clinic

TRANSORAL ENDOSCOPIC THYROIDECTOMY VIA THE VESTIBULAR APPROACH (TOETVA) IN PATIENTS WITH GRAVES' DISEASE: A NORTH AMERICAN CASE SERIES

Endocrine Surgery

Katherine Tai¹; Sallie Long, MD¹; Victoria Yu, MD¹; Rachel Weitzman¹; Victoria Banuchi, MD¹; Jonathon Russell, MD²

¹Weill Cornell Medicine Otolaryngology Head and Neck Surgery; ²Johns Hopkins Otolaryngology-Head and Neck Surgery

RISK STRATIFICATION OF LATERAL NECK RECURRENCE FOR PN1A PAPILLARY THYROID CANCER BASED ON THE NUMBER OF CENTRAL METASTATIC LYMPH NODES AND PRIMARY TUMOR SIZE

Endocrine Surgery

Siyuan Xu; Hui Huang; Shaoyan Liu; Jie Liu

Department of Head and Neck Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

NEOADJUVANT SELECTIVE RET INHIBITOR FOR MEDULLARY THYROID CANCER: A CASE SERIES

Endocrine Surgery

Kevin J Contrera, MD, MPH; Maria K Gule-Monroe, MD; Maria E Cabanillas, MD; Mimi I Hu, MD; Naifa L Busaidy, MD; Ramona Dadu, MD; Steven G Waguespack, MD; Jennifer Wang, MD; Jeffery Myers, MD, PhD; Elizabeth G Grubbs, MD; Vivek Subbiah, MD; Michelle D Williams, MD; Mark E Zafereo, MD

UT MD Anderson Cancer Center

SHARED DECISION-MAKING IN THE MANAGEMENT OF INDETERMINATE THYROID NODULES

Endocrine Surgery

David Forner, MD, MSc¹; Victoria Taylor, BA¹; Christopher W Noel, MD²; Brooke Turner, MD¹; Paul Hong, MD, MSc¹; Stephanie Johnson-Obaseki, MD, MPH³; David P Goldstein, MD, MSc²; Matthew H Rigby, MD, MPH¹; S. Mark Taylor, MD¹; Jonathan R Trites, MD¹; Martin Corsten, MD¹

¹Dalhousie University; ²University of Toronto; ³University of Ottawa

HEALTH CARE DISPARITIES AND RATES OF MALIGNANCY AMONGST CHILDREN WITH SINGLE THYROID NODULES

Endocrine Surgery

Z. Jason Qian, MD¹; Eric Pineda, BS²; Hilary Seeley, MD¹; Gary Hartman, MD¹; Julia Noel, MD¹; Lisa A Orloff, MD¹; Kara D Meister, MD¹

¹Stanford University; ²Tulane University

COMPARISON OF RISK FACTORS AND POSTOPERATIVE OUTCOMES IN PRIMARY AND SECONDARY/TERTIARY HYPERPARATHYROIDISM

Endocrine Surgery

Ryan M Kong, BS; Jennifer Liang, MD; Natalya Chernichenko, MD

SUNY Downstate Health Sciences University

FACTORS ASSOCIATED WITH REFUSAL OF SURGERY IN DIFFERENTIATED THYROID CARCINOMA

Endocrine Surgery

Aman Prasad, BS¹; Ryan M Carey, MD²; Robert M Brody, MD²; Steven B Cannady, MD²; Jason G Newman, MD²; Jason Brant, MD²; Karthik Rajasekaran, MD²

¹Perelman School of Medicine at the University of Pennsylvania; ²Department of Otorhinolaryngology: Head and Neck Surgery, University of Pennsylvania, Perelman School of Medicine

THE VALUE OF SECOND OPINIONS ON THYROID NODULE MANAGEMENT PROVIDED VIA DIRECT-TO-CONSUMER TELEMEDICINE SERVICE

Endocrine Surgery

Samuel Dudley, MD; Marion B Gillespie, MD

University of Tennessee Health Science Center